The Hippo

HOME| ADVERTISING | CONTACT US|

Protein Clumps May Indicate Memory Problems Manchester NH

Amyloid protein deposits in the brain play a role in disrupting the memory formation process long before a person shows symptoms of the memory impairment of Alzheimer's disease, a new study contends.

South Willow Animal Hospital
(603) 641-6252
575 South Willow Street
Manchester, NH

Data Provided by:
Northside Animal Hospital
(603) 622-5299
574 Arah Street
Hooksett, NH

Data Provided by:
Healing Hands Chiropractic Family Wellness Ce
(603) 434-3456
156 Harvey Rd
Londonderry, NH

Data Provided by:
Derry Animal Hospital
(603) 432-3700
28 Tsienneto Road
Derry, NH

Data Provided by:
Pain Relief Center
(603) 886-4500
163 Amherst St
Nashua, NH

Data Provided by:
Daniel Webster Animal Hospital
(603) 624-4004
3 Hawthorne Dr.
Bedford, NH

Data Provided by:
HealthSource of Londonderry
(603) 624-6100
298 Rockingham Road
Londonderry, NH

Data Provided by:
Merrimack Veterinary Hospital
(603) 424-9922
235 Daniel Webster Hwy
Merrimack, NH

Data Provided by:
Ponemah Veterinary Hospital
(603) 673-5300
199 Rte 101
Amherst, NH

Data Provided by:
Hampstead Animal Hospital
(603) 329-7825
472 Route 111
Hampstead, NH

Data Provided by:
Data Provided by:

Protein Clumps May Indicate Memory Problems

Provided By:

Amyloid protein deposits in the brain play a role in disrupting the memory formation process long before a person shows symptoms of the memory impairment of Alzheimer's disease, a new study contends.

Previous research had suggested that clumps of amyloid protein, which damage neurons and are characteristic of Alzheimer's disease, begin appearing many years before Alzheimer's symptoms appear. But the link between the deposits and memory impairment had not been clearly demonstrated in humans.

In the new study, which appears in the July 30 issue of Neuron, U.S. researchers used medical imaging to examine the brains of older people who did not have significant memory impairment.

"Two recent advances in neuroimaging now allow us to explore the early, asymptomatic phase of , the ability to measure amyloid distribution in living humans and the identification of sensitive markers of brain dysfunction" in the disease, Dr. Reisa Sperling, of the Center for Alzheimer's Research and Treatment at Brigham and Women's Hospital in Boston and lead author of the study, said in a news release from the journal's publisher.

The researchers found that a number of study participants had amyloid deposits and abnormal activity in areas of the brain believed to be involved in memory function.

The results could help in efforts to find ways to predict and treat cognitive decline in people at risk for Alzheimer's, the study authors noted.

"Longitudinal studies are certainly needed, but our findings are consistent with the premise that cognitively intact older individuals with amyloid pathology may already be in the early stages of ," Sperling said. "The combination of molecular and functional imaging techniques may prove useful in monitoring disease progression prior to significant clinical symptoms, as well as the response to amyloid-modifying therapeutic agents in subjects at risk for developing ."

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.

SOURCE: Cell Press, news release, July 29, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

®2010 Hippo Press. site by wedu